Apoglyx Competitors and Similar CompaniesClear all
Apoglyx's competitors and similar companies include BIOTON and Viking Therapeutics.
 Apoglyx Apoglyx is a biotech company developing a small molecule oral therapy for type 2 diabetes patients. |  Viking Therapeutics Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of therapies for metabolic and endocrine disorders. | ||
Founding Date | Founding Date 2015 | Founding Date 1989 | Founding Date 2012 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Malmö, SE HQ Lund, SE | Locations Macierzysz, PL HQ | Locations San Diego, US HQ |
Employees | Employees 525% increase | Employees 361 | Employees 2729% increase |
Financial | |||
Net income | Net income N/A | Net income zł3.4m (FY, 2025) | Net income ($359.6m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
BIOTON
HQ
Macierzysz, PL
Employees
361
Bioton is a biotech company whose major therapeutic area is diabetes.
View companyViking Therapeutics
HQ
San Diego, US
Employees
27↑ 29% increase
Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of therapies for metabolic and endocrine disorders.
View company